Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. - Wikidata - wikimedia - TriplyDB

Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.

Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q35566819

about

Cardiovascular disease in lupus: insights and updates P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.A meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those without An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors DNA-responsive inflammasomes and their regulators in autoimmunity Targeting the inflammasome in rheumatic diseases.Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients.Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair.Isoflurane attenuates murine lupus nephritis by inhibiting NLRP3 inflammasome activation.Modulation of Endothelial Injury Biomarkers by Traditional Chinese Medicine LC in Systemic Lupus Erythematosus Patients Receiving Standard Treatments.Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus.Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions Neutrophil Extracellular Traps and Systemic Lupus Erythematosus.Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation.Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.Ten developments in the use of biologicals for systemic lupus erythematosus.Gene expression and regulation in systemic lupus erythematosus.New paradigms in inflammatory signaling in vascular endothelial cells.The effects of Eculizumab on the pathology of malignant atrophic papulosis.Targeting interferons in systemic lupus erythematosus: current and future prospects.Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.Inflammasome activation by nucleic acids and nucleosomes in sterile inflammation… or is it sterile?Update on cardiovascular disease in lupus.Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.Inflammasomes link vascular disease with neuroinflammation and brain disorders.Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.Vascular precursor cells in tissue injury repair.Serum levels of cytokines in systemic lupus erythematosus : Association study in a Chinese population.Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.Hyperactivation of the NLRP3 Inflammasome in Myeloid Cells Leads to Severe Organ Damage in Experimental Lupus.Association between functional NLRP3 polymorphisms and susceptibility to autoimmune and inflammatory diseases: a meta-analysis.Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

P2860

Q27016554-7B843062-E130-4D46-9387-952EA9C0AD63 Q30409205-62232955-F43C-4C52-B860-C13F57FCE34B Q31142463-29BBA2D1-94C3-4648-BC34-93B3894B2AC9 Q34055844-470E4A46-0464-43C5-83C5-E21EF7B34A64 Q34127758-6DFF7947-8619-4ACD-8261-930088B2E26E Q34343906-5EA2F68D-73F6-4EA6-BFCE-56CE4E895803 Q35661943-A09658CA-C9D7-4B1C-9CA2-EC0C7D6E51B1 Q35785671-6C5C1716-DC2B-4CC4-9709-CD0A8F374001 Q35804717-250AA40B-2982-423B-9785-339D60F391B8 Q36207088-B926CF57-6FC4-47E2-A061-793DE68D903D Q36410356-15782FFB-16DB-4430-B3FE-B08D6C7B3302 Q36411613-7A94C19A-547D-4A56-B75C-E2B83CDF0E85 Q36548651-CFD36E69-F0B3-46F3-9D87-53F27263A6B2 Q36553792-44AAE51D-7B59-475B-B894-02C958287C1C Q36729072-A26AB3D2-A6FA-445F-8017-E60CF70C161F Q36746012-8FFDC58B-A118-45B6-BC12-73831B05BF79 Q37306015-2351889E-DF66-4376-AB66-27C714075B6B Q37332300-B5D7857F-8135-4065-A107-D99A49C65064 Q37426823-EE9E8520-DC9B-4895-A9B3-ED2431104BE9 Q37699393-614ABBF3-AF83-4410-8325-756079C4423C Q37699812-CA6B2C59-BEB8-4EB8-8B7D-F84C5198EF35 Q38004932-5EC764FD-71A3-412A-B647-AB638E1339ED Q38085723-D8616353-63BA-4138-A56D-9DDDAE4EB75B Q38105959-6AC16D89-0D26-4530-90EA-248E43868A73 Q38125510-5F1A66F6-E751-4B8C-8862-8BB30473B78E Q38166953-E8AAA8CA-BCF3-4F19-A6E1-0D81C8ED2767 Q38394033-17EB3011-E0FB-4230-9BF2-6911D6CA14B1 Q38458846-B4972F9D-C88D-4328-917C-0E37C2E1B5A0 Q38554636-ACBCA849-3EF9-4310-A721-B70731276236 Q38735363-6D51616F-E39A-46E8-A95B-4770358F789D Q38844782-9E2BABB3-BBE0-4306-8E19-948D393B7C8C Q38857518-4A507867-5311-4723-A20D-7DFB7E71D54F Q38916890-2D2AE5EE-E8E2-4490-948F-B1297404F8AA Q38926368-62CE7EFE-47BC-40C4-851D-8C874C37E795 Q39174289-508191A8-2268-45A8-A068-584B2A9280F5 Q39300581-ED0CAB83-1CF4-487F-B097-5CCC6E0F55D5 Q39586997-77D30B81-7ABC-4AAD-A099-79BF3D39AAB9 Q40401297-65A9A4B2-0610-4E18-94C9-E529B23D078B Q40502550-3EAF51AA-75AA-4435-8A62-63935DC0282C Q42145401-68103A13-626F-4DF9-B147-73495A2378DF

P2860

Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q35566819

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Inflammasome activation of IL- ...... systemic lupus erythematosus.

@ast

Inflammasome activation of IL- ...... systemic lupus erythematosus.

@en

type

label

Inflammasome activation of IL- ...... systemic lupus erythematosus.

@ast

Inflammasome activation of IL- ...... systemic lupus erythematosus.

@en

prefLabel

Inflammasome activation of IL- ...... systemic lupus erythematosus.

@ast

Inflammasome activation of IL- ...... systemic lupus erythematosus.

@en

P1433

Q35566819-DCCB7F7F-8552-4C0A-A491-B98EB8693CC7

P1476

Q35566819-000DD564-8AF0-4A61-B3F7-12FD6409FFF6

P2093

Q35566819-0AD62E3E-40BD-45B9-89AF-BC5C9C69B2EE

Q35566819-41750000-D0D0-4D69-A423-100F196B5348

Q35566819-48D85A5D-B209-41CF-BC67-538E794416E9

Q35566819-5B197119-BF26-48DF-BCCD-503B27694A80

Q35566819-8A01B171-6479-4B2E-8DF8-8665FFFD32CF

Q35566819-E3BCA7FE-4B4C-4C04-82D0-B39494E5E097

P2860

Q35566819-0015F65D-CB55-4F2F-9FFC-01B4F3F6092C

Q35566819-1130897B-BF40-4E0B-8E48-A0E359162D9A

Q35566819-117385CF-0962-4837-865B-B69558A7DF32

Q35566819-1FC348E7-369D-4532-BE30-5EF1BA39A536

Q35566819-25FFC640-39DA-4CCD-AB9C-74D72CF55A8F

Q35566819-29C23668-B241-44F5-9FA8-C8FF6F93F7C5

Q35566819-2C4C1A88-FCC4-443A-9C43-EE6E649B0F0B

Q35566819-2E5C21EA-D575-4946-9CCD-6D7275EE7AEF

Q35566819-2FDECD09-BB81-452D-825F-B6F420897F91

Q35566819-32B90289-6B6F-4087-838B-565ADBB34D98

P304

Q35566819-97FA7F23-6D86-4703-A82A-01656A87C256

P31

Q35566819-E118A745-343A-4841-8ED6-F72A9AEF9D4B

P356

Q35566819-0745268C-4A97-4040-A980-811A66A2F0B1

P407

Q35566819-9368077F-F03A-4205-9834-5C2F72A663AF

P433

Q35566819-3E323DFD-01F6-4B73-AC0C-DAF5906492A1

P478

Q35566819-738AF379-9555-484E-88F0-AD6E064A3BC7

P577

Q35566819-C1495CE6-7EC8-43D7-9B45-3F5B5026D553

P5875

Q35566819-48A563EB-916C-482C-A992-35FDE4819556

P698

Q35566819-2C35064C-89E9-4AF1-8B01-005834C7F404

P921

Q35566819-66912993-BA42-4551-8938-2EAA72808F46

Q35566819-F2D374A4-C7D7-4EC3-9D03-EB126622A8E7

P932

Q35566819-E271188F-F94C-4868-9C01-D827B279B08A

P356

JIMMUNOL.1101284

P1433

Journal of Immunology

P1476

Inflammasome activation of IL- ...... systemic lupus erythematosus.

@en

P2093

Celine C Berthier

http://www.w3.org/2001/XMLSchema#string

Clemens D Cohen

http://www.w3.org/2001/XMLSchema#string

J Michelle Kahlenberg

http://www.w3.org/2001/XMLSchema#string

Mariana J Kaplan

http://www.w3.org/2001/XMLSchema#string

Matthias Kretzler

http://www.w3.org/2001/XMLSchema#string

Seth G Thacker

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of type-I- and type-II-interferon-mediated signalling

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

The 1982 revised criteria for the classification of systemic lupus erythematosus

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb.

Interleukin-18.

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.

A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs

P304

6143-6156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1101284

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51774820

http://www.w3.org/2001/XMLSchema#string

P698

22058412

http://www.w3.org/2001/XMLSchema#string

P921

P932

3221936

http://www.w3.org/2001/XMLSchema#string